Cogent Biosciences, Inc. <COGT.O>: Leerink Partners Cuts Target Price to $60 From $72
COGT•Related News
Salesforce, Inc. <CRM.N>: UBS Raises Target Price to $210 from $185
CRM•
Nasdaq trade halt <OFAL.O> volatility trading pause at 09:36 am
OFAL•
California Resources Corporation <CRC.N>: UBS Cuts Target Price to $67 From $70
CRC•
Dot Ai appeals Nasdaq delisting notice after failing $50 million market value rule
DAIC•
Ukraine halts strikes on tankers using Russian port at US request, FT says
XLE•